A Streamlined CDMO
Pioneering the accelerated development and commercialization of cell and gene therapies
Website under development, more info on our enabling platforms coming soon.
Develop, manufacture, and release your advanced therapies faster and with greater predictability.
Click below to speak to a technical specialist today
USP 665 BPOG Extractables and Leachables SUS and Risk Assessment a webinar that provides clarity
USP 665, BPOG, Extractables and Leachables, SUS, and Risk Assessment; a webinar that provides clarity. For single use components, conducting an Extractables and Leachables (E/L) study to quantify all known chemicals combined with a toxicological risk assessment are...
read moreNohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec To Manufacture Universal Donor Cell Therapies
WuXi AppTec Advanced Therapies will manufacture Nohla's cell therapies at their Philadelphia Navy Yard campus, which features over 220,000 square feet of GMP compliant manufacturing space. Nohla Therapeutics, a leading developer of universal donor cell therapies for...
Philadelphia Career Event
You're Invited! Philadelphia Career Event. WuXi AppTec’s Advanced Therapies business unit is actively searching for talent to help accelerate the development and commercialization of cell and gene therapies. We will be hosting a free career and networking event at our...
Suspension Platforms
Process
Development
Manufacturing
Testing
Development